Highlights

  • FY26 Revenue reached AUD 21.6 million, including AUD 7.6 million of milestone revenue.
  • The FY26 net loss narrowed to AUD 38.6 million.
  • The Paducah enrichment proposal remains subject to licensing, feasibility and Investment decisions.
  • A separate silicon-28 production Facility was completed in June 2026, ahead of commissioning.

Silex Systems (ASX:SLX) develops laser-based technologies for uranium enrichment and the production of specialised silicon materials. Unlike an operating uranium producer, its current financial performance depends heavily on technology development and milestone arrangements. FY26 revenue reached AUD 21.6 million, an increase of AUD 9.4 million, including AUD 7.6 million of milestone revenue associated with the laser enrichment programme. The net loss narrowed to AUD 38.6 million from AUD 42.6 million. These figures do not indicate commercial-scale enrichment earnings; the principal project remains in development.

Laser enrichment and development milestones

Silex Systems (ASX:SLX) holds a 51% interest in the company licensed to commercialise its uranium laser enrichment technology. The technology reached Technology Readiness Level 6, reflecting a validated demonstration stage rather than commercial deployment. Work is progressing towards a higher readiness level through full-scale design and demonstration. Technical readiness matters because commercial performance must be established at the intended operating scale, with reliability, Economics and regulatory compliance all demonstrated before revenue from large-scale operations can be assumed.

Milestone receipts are linked to particular development achievements and may not recur at the same level every year. Silex Systems (ASX:SLX) therefore has a different revenue profile from a Business selling an established product continuously. Research, engineering and regulatory work can continue for several reporting periods before a project reaches a final investment decision. The timing and cost of those activities influence the company's funding needs.

Paducah project and regulatory process

The proposed Paducah Laser Enrichment Facility in Kentucky is intended to re-enrich depleted uranium material. The development concept covers more than 200,000 tonnes of depleted uranium tails. Management has described a possible commercial operation from 2030, while also cautioning that project timelines are tentative. The project requires technical completion, regulatory approval, commercial agreements and financing. A proposed output scale should not be treated as existing production or a mineral resource.

In March 2026, a draft environmental impact statement was published in the US licensing process, with a licensing decision expected in early calendar 2027 according to the supplied material. A US government funding award of USD 28.5 million was announced in January 2026, and preliminary state and local incentives of up to USD 98.9 million were approved in March subject to conditions. These amounts are not interchangeable with cash already received or with full project financing. Silex Systems (ASX:SLX) also disclosed in January 2026 that the project was not selected for a separate, larger federal enrichment programme.

Quantum Silicon and financial considerations

Silex Systems (ASX:SLX) is developing highly enriched silicon-28 for prospective Quantum Computing applications. Construction of its Sydney production facility was completed in June 2026, with commissioning and sample production still to follow. The initial capacity objective is up to 20 kilograms annually. A completed facility does not establish commercial sales, particularly where end-market Demand depends on the progress of quantum computing customers.

The group previously raised Capital to support development, and ongoing expenditure remains relevant while its projects are pre-commercial. A final investment decision for Paducah has not been announced in the supplied material. Future funding structure, technology demonstration, licence decisions and customer agreements will determine how development proceeds. These are material uncertainties rather than routine operating milestones.

Key Insights

Silex Systems (ASX:SLX) increased FY26 revenue through development milestones while continuing to report a net loss. The Paducah project is not yet a commercial enrichment operation, and its indicative timetable remains conditional. Regulatory decisions, demonstration performance, project financing and the commissioning of the silicon-28 facility are the key distinctions between announced progress and completed commercial delivery.